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Introduction
Parkinson’s disease (PD) is the second most common late-onset 
neurodegenerative disease. The muscle rigidity, tremor, and brady-
kinesia that are characteristic of PD patients are thought to be 
caused by cell death of dopaminergic neurons found in the sub-
stantia nigra. Interestingly, the cognitive and behavioral impair-
ments seen in PD patients indicate the degeneration of other areas 
of the brain outside of the substantia nigra.
PD pathology is characterized by the formation of intra-
neuronal inclusions called Lewy bodies, which are comprised 
mainly of -synuclein. Although PD is largely a sporadic disease, 
familial forms have revealed -synuclein as a causal gene. Mu-
tations in the -synuclein gene, including point mutations and 
multiplications of the entire locus, have been shown to cause 
familial forms of PD, whereas increased severity of PD and 
earlier age of onset have been reported to correlate with increased 
-synuclein dosage (Ross et al., 2008). Thus, wild-type 
-synuclein is a likely toxic mediator in sporadic PD and is cen-
tral to understanding the molecular pathogenesis of this disease.
One potential mechanism of -synuclein toxicity has origi-
nated from elegant studies in yeast overexpressing this protein. 
These studies showed that wild-type -synuclein perturbed the 
secretory pathway by inhibiting the activity of Rab1. Although 
the studies showed that Rab1 overexpression rescued -synuclein 
toxicity in animal models, they did not show that the secre-
tory pathway was affected by this protein in mammalian cells 
(Cooper et al., 2006; Gitler et al., 2008). Another nonmutually ex-
clusive mechanism is that modified forms of -synuclein appear 
to affect chaperone-mediated autophagy (CMA; Cuervo et al., 
2004). In CMA, a proportion of cytoplasmic proteins are directly 
translocated into the lysosome without involvement of vesicular 
intermediates or autophagosomes, macroautophagy organelles. 
Although CMA is a very plausible contributor to pathology, it 
may not be the only protein degradation pathway affected, es-
pecially because the phenotype of LAMP2A/CMA-null mice is 
relatively benign (Massey et al., 2006). Studies have also shown 
a possible connection between -synuclein and 26S proteasome 
dysfunction (McNaught et al., 2001, 2003; Snyder et al., 2003). 
-Synuclein exists in three common forms, monomers, dimers, 
and protofibrils, and it is thought that an overabundance of the 
protofibril form inhibits ubiquitin-proteasome activity in vitro 
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Figure 1. Overexpression of -synuclein inhibits macroautophagy. (A) Bar graph indicating the effect of -synuclein–GFP overexpression on HA-tagged 
httQ74 aggregation in SKNSH, human neuroblastoma cells (odds ratio; n = 9). Note that the number of control cells with httQ74 aggregates can differ 
under varying experimental setups because of different cell lines, different transfection conditions (e.g., whether httQ74 is transfected along with another 
expression vector or siRNA), and time. Therefore, the relative change of the experimental condition is important. (B) Effect of -synuclein overexpression on 
tomato-tagged p62. Tomato-p62 and DsRed (1.5:1) were transfected for the last 24 h of the experiment at low levels to observe the effect of -synuclein 
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overexpression on p62. DsRed was used as a transfection control for tomato-p62 (two-tailed Student’s t test; n = 3). (C) Effect of -synuclein overexpres-
sion on LC3-II levels treated with and without bafilomycin A1. Tubulin levels demonstrate equal loading. Densitometry for a representative dataset (n = 3) 
with and without bafilomycin are shown (two-tailed Student’s t test). (D) Immunostaining of endogenous LC3-positive puncta in SKNSH cells overexpressing 
-synuclein–GFP. The boxes in the third column are magnified in column four to show more detail of the differences in autophagosome number at high mag-
nification. Images shown are z-stack projections. Bars, 20 µm. (E) Bar graph indicating the effect of -synuclein overexpression on LC3 vesicle number (two-
tailed Student’s t test; n = 20). (F) LC3-II levels assessed by SDS-PAGE in right hemisphere brain lysates from wild-type mice (+,+) and mice heterozygous 
(+/M7) and homozygous (M7/M7) for the -synuclein transgene (M7). Representative samples are shown. (G) Quantification of LC3-II levels from F relative 
to tubulin by densitometry (one-way ANOVA and Bonferroni post hoc test; n = 3). (A–C, E, and G) Error bars represent SEM (*, P < 0.05; **, P < 0.01; 
***, P < 0.001). (H) Neuronal expression of -synuclein (-syn; UAS--synuclein) using the elav-Gal4 driver (elav-Gal4; elavC155) significantly increased 
neurodegeneration of flies expressing mutant huntingtin exon-1 (Q120; gmr-Htt(exon1) Q120) in eyes (*, P < 0.02 for comparisons to all controls; paired 
Student’s t test; n = 5 independent experiments each based on 15 ommatidia from each of 10 individuals). Error bars represent SEM.
 
(McNaught et al., 2001, 2003; Snyder et al., 2003; Zhang et al., 
2008), although these studies remain controversial, especially 
in vivo (Dyllick-Brenzinger et al., 2010).
Macroautophagy is the major lysosomal pathway by which 
cells degrade intracytoplasmic proteins. Macroautophagy, which 
we will henceforth call autophagy, is distinct from CMA, as 
macroautophagy is responsible for nonspecific, bulk degradation 
of cytoplasmic contents and relies on vesicular trafficking rather 
than direct import of substrates into lysosomes. Autophagy initi-
ates when cells form double layered autophagosomes around a 
portion of cytoplasm. Autophagosomes ultimately fuse with lyso-
somes where their contents are degraded. This pathway, which is 
conserved from yeast to man, is essential for a range of normal 
physiological functions. Mice defective for macroautophagy die 
soon after birth, and neuronal knockouts of such genes cause 
neurodegeneration accompanied by inclusion formation (Kuma 
et al., 2004; Komatsu et al., 2005). Autophagy appears to impact 
multiple pathways relevant to neurodegeneration, as it is a key 
route for the degradation of a range of intracytoplasmic aggregate-
prone proteins (which are a feature of most neurodegenerative 
diseases) and is also a disposal route for dysfunctional mito-
chondria (organelles implicated in many diseases, including PD). 
One disease-associated autophagy substrate is mutant huntingtin 
(associated with Huntington’s disease [HD]), and the proportions 
of cells with mutant huntingtin aggregates increase when autoph-
agy is impaired (Ravikumar et al., 2002). In this sense, the per-
centage of cells with mutant huntingtin aggregation can serve as 
a sensitive indicator of autophagic substrate clearance (Klionsky 
et al., 2008). Therefore, we considered that autophagy may be 
perturbed by -synuclein because we had previously noticed that 
the percentage of cells with huntingtin aggregates is enhanced 
when cells also overexpress -synuclein (Furlong et al., 2000) 
and that this was not caused by an association between the two 
proteins (Furlong et al., 2000).
Results
Overexpression of wild-type -synuclein 
inhibits macroautophagy
We confirmed our previous observation that -synuclein over-
expression increased the percentage of cells with huntingtin 
aggregates (Fig. 1 A; Furlong et al., 2000), a phenomenon which 
occurs when autophagy is compromised. We further observed that 
overexpression of -synuclein also increased levels of another 
autophagy substrate, p62 (Fig. 1 B).
The standard means of assaying autophagy directly is to 
measure the levels of autophagosome-associated LC3. Processing 
of microtubule-associated protein 1 light chain 3B, also known as 
LC3, creates two forms of LC3 identifiable by immunoblot-
ting. Initially, the LC3 precursor is cleaved to form LC3-I, a 
cytoplasmic, active form of the protein that does not associ-
ate with autophagosomes. Further lipidation of LC3-I creates 
the autophagosome-associated form, LC3-II, which is known 
to be a robust marker of autophagosomes (Kabeya et al., 2000). 
Although LC3-I can be detected by Western blotting, it is known 
to be largely unreliable as an indicator of autophagy because 
of both the instability of the protein in cell lysates and its non-
association with autophagosomes. LC3-II levels (as a function 
of actin or tubulin) correlate with autophagosome number; the 
consensus statement on autophagy methodology is that LC3-II 
should be related to actin/tubulin loading controls and not to 
LC3-I (see Klionsky et al. [2008] for a detailed discussion; 
Rubinsztein et al., 2009). Alternatively, immunofluorescent stain-
ing of LC3 can be used to assay autophagosome formation.
LC3-II levels (Fig. 1 C) and the number of LC3 vesicles 
(Fig. 1, D and E) were decreased in cells overexpressing wild-
type -synuclein, compared with cells transfected with empty 
vector, and this was specific to wild-type -synuclein as the 
PD-associated -synuclein mutants A53T and A30P had no effect 
on LC3-II levels (Fig. S1 A). Although there was a tendency for 
decreased vesicle size with both -synuclein overexpression and 
Rab1a knockdown (see Rab1a regulates authophagy), this was 
not statistically significant but was always accompanied by a sig-
nificant decrease in the number of vesicles per cell. LC3-II levels 
can change either because of changes in the rate of LC3-II syn-
thesis or changes in the rate of LC3-II degradation. These scenar-
ios can be deconvoluted by assaying LC3-II levels in the presence 
of saturating levels of bafilomycin A1, which blocks LC3-II deg-
radation and allows for specific assessment of LC3-II formation 
rates (as described in detail in Rubinsztein et al. [2009]). We con-
firmed that the decrease in LC3-II levels caused by -synuclein 
was caused by impaired autophagosome synthesis, as LC3-II 
levels were also decreased in cells overexpressing -synuclein 
when the cells were treated with bafilomycin A1 (Fig. 1 C). Con-
sistent with the data, knockdown of -synuclein increased LC3-II 
levels in the presence and absence of bafilomycin A1 (Fig. S1 B) 
and reduced the percentage of cells with huntingtin aggregates 
(Fig. S1 C; we used HeLa cells in this experiment as they allow 
more efficient siRNA silencing compared with neuronal cells). 
LC3-II levels were also decreased in the brains of mice over-
expressing -synuclein, suggesting that the effects we see in cell 
culture are present in vivo (Fig. 1, F and G). Our data suggested 
that the effect of the -synuclein transgene on LC3-II levels was 
dose dependent in the mouse brains. We fitted a dose-dependent 
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a modest but reproducible inhibition of constitutive secretion in 
mammalian cells (Fig. 2 A). Cells overexpressing -synuclein 
also showed increased Golgi fragmentation (Fig. 2, B and C), 
a phenotype generally caused by secretory defects (e.g., with 
Rab1a siRNA knockdown; Fig. S2 A). Consistent with these 
findings, increased Golgi fragmentation has been observed in 
postmortem PD brain sections in comparison with healthy con-
trols (Fujita et al., 2006).
regression model for the effects of transgene dose (0, 1, or 2) 
on LC3-II levels and found statistical evidence supporting an 
association (P = 5.35 × 103). To allow for the small number of 
samples analyzed, we also performed a permutation test, which 
confirmed the association P = 0.89 × 103 (789/100,000 permu-
tations had a larger test statistic than observed in the original 
test). It is not possible to assess whether the decrease in auto-
phagosome numbers seen in the -synuclein mouse brains is 
caused by decreased formation or increased delivery of auto-
phagosomes to lysosomes. However, the decrease we see in 
LC3-II levels in the mouse brain is consistent with the definitive 
decrease in autophagosome formation we observe in cells with 
overexpression of -synuclein.
The compound eye of Drosophila melanogaster consists 
of many ommatidia, each composed of eight photoreceptor neu-
rons with light-gathering parts called rhabdomeres, seven of 
which can be visualized by light microscopy using the pseudo-
pupil technique (Franceschini and Kirschfeld, 1971). Fly photo-
receptors that express a mutant huntingtin fragment with 120 
polyglutamine repeats exhibit photoreceptor degeneration that 
is not observed in flies that express the wild-type fragment with 
23 polyglutamine repeats (Jackson et al., 1998). Neurodegener-
ation in HD flies is progressive and is associated with a decrease 
in the number of visible rhabdomeres in each ommatidium over 
time (Jackson et al., 1998). This fly model can be used to assay 
modulators of neurodegeneration. When autophagy is impaired, 
cells accumulate aggregate-prone, intracytoplasmic proteins 
and become more susceptible to apoptotic insults (Ravikumar 
et al., 2006). We have previously shown that treatment of mutant 
huntingtin-expressing flies with genetic or chemical inhibitors 
of autophagy increases neurodegeneration within the fly eye 
(Ravikumar et al., 2005, 2008). If -synuclein inhibits autophagy, 
neurons expressing mutant huntingtin, as a model aggregate- 
prone toxic protein, would be predicted to degenerate more 
rapidly upon coexpression with -synuclein. Consistent with 
our hypothesis, the toxicity of the HD mutation was enhanced 
by the presence of wild-type -synuclein (Fig. 1 H). Although 
we cannot exclude that -synuclein is also enhancing mutant 
huntingtin toxicity via autophagy-independent pathways, our cell 
biology data suggest that the effects on autophagy are signifi-
cant contributors.
Overexpression of wild-type -synuclein 
inhibits secretion in mammalian cells
Early studies in yeast identified a potential dependence of autoph-
agy on proper functioning of the secretory pathway (Ishihara 
et al., 2001; Hamasaki et al., 2003; Reggiori et al., 2004). Given 
the results of previous studies showing that -synuclein inhibits 
secretion in yeast and in vitro by disrupting Rab1a homeostasis 
(Cooper et al., 2006; Gitler et al., 2008), we considered the possi-
bility that defects in the secretory pathway caused by -synuclein 
at the levels of ER to Golgi transport may underlie the autophagy 
defect we have observed in mammalian cells. To study the effect 
of -synuclein on ER to Golgi transport in mammalian cells, we 
used a pharmacologically controlled secretion system that is able 
to sensitively measure changes in constitutive secretion. This assay 
showed that overexpression of wild-type -synuclein caused 
Figure 2. Overexpression of -synuclein inhibits secretion and causes 
Golgi fragmentation in mammalian cells. (A) Bar graph indicating the 
effect of -synuclein–CFP overexpression on constitutive secretion in a 
HeLa-derived reporter cell line (C1). Brefeldin A, a known inhibitor of 
constitutive secretion, was used as a positive control (*, P < 0.05; two-
tailed Student’s t test; n = 3). GH, growth hormone. (B) Immunostaining 
of endogenous GM130 (cis-Golgi marker) in HeLa cells overexpressing 
-synuclein–GFP. Images are z-stack projections. Bars, 20 µm. (C) Quanti-
fication of -synuclein effect on Golgi fragmentation (***, P < 0.001; odds 
ratio; n = 6). (A and C) Error bars represent SEM.
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Rab1 enhanced the toxicity of mutant huntingtin fragments 
(Fig. 3 D). Thus, Rab1a deficiency regulates autophagy and 
mimics the effects of -synuclein overexpression on autoph-
agy and related phenotypes. It is important to note that over-
expression of -synuclein does not affect Rab1a protein levels 
in either cells or mice brain lysates, which is consistent with 
an effect of -synuclein on Rab1a activity rather than protein 
levels (Fig. S2 B).
Given the role of Rab1a in secretion, we wanted to de-
termine whether Rab1a regulates autophagy independently of 
Rab1a regulates autophagy
We tested whether Rab1a knockdown regulated autophagy. 
As there is no known specific inhibitor of Rab1a activity, we 
used knockdown experiments to simulate loss of Rab1a func-
tion. siRNA knockdown of Rab1a decreased LC3-II levels in 
the presence and absence of bafilomycin A1 (Fig. 3 A). Rab1a 
knockdown increased the percentage of cells with mutant 
huntingtin aggregates (Fig. 3 B). A constitutively active form 
of Rab1 suppressed mutant huntingtin toxicity in Drosoph-
ila photoreceptors (Fig. 3 C), whereas a dominant-negative 
Figure 3. Knockdown of Rab1a inhibits macroautophagy. (A) LC3-II levels were assessed by SDS-PAGE after knockdown of Rab1a and treatment with 
bafilomycin A1 in HeLa cells. Actin levels demonstrate equal loading. Densitometry for a representative dataset (n = 3) with and without bafilomycin are 
shown (*, P < 0.05; Student’s t test). (B) Bar graph indicating the effect of Rab1a knockdown, as in A, on aggregation of httQ74-HA (***, P < 0.001; 
odds ratio; n = 9). (A and B) Error bars represent SEM. (C) Neuronal expression of constitutively active Rab1 (Rab1-CA; UASp-YFP.Rab1.Q70L) using 
the elav-Gal4 driver significantly suppressed neurodegeneration of 5-d-old flies expressing mutant huntingtin exon-1 (Q120; 5.0 ± 0.12 and 4.1 ± 0.06 
rhabdomeres, in the presence and absence of Rab1-CA, respectively; P ≤ 0.005, by Student’s t test). Each normal fly eye contains hundreds of ommatidia 
with seven visible rhabdomeres. The graphs show the distributions of the numbers of rhabdomeres per ommatidium for each of the genotypes. Comparisons 
were performed using the paired Student’s t tests using data from five to seven independent experiments, each based on 10 individuals of each genotype, 
in which 15 ommatidia each were scored. (D) Neuronal expression of dominant-negative Rab1 (Rab1-DN; UAST-YFP.Rab1.S25N) using the elav-Gal4 
driver significantly enhanced neurodegeneration of 5-d-old flies expressing mutant huntingtin exon-1 (Q120; 4.1 ± 0.1 and 5.2 ± 0.1 rhabdomeres, in the 
presence and absence of Rab1-DN, respectively; P < 0.02, by Student’s t test). Note that the different levels of neurodegeneration in the Q120 elav-Gal4 
flies between C and D is likely because these were independent experiments, in which the duration was not identical.
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Figure 4. Autophagy is not dependent on 
all Rab proteins that regulate secretion. (A) To 
measure the effect of RNAi of Rab1a, Rab1b, 
Sar1A/B, Giantin, and VDP on constitutive secre-
tion, HeLa-derived C1 cells were transfected with 
siRNA corresponding to these genes. The amount 
of GFP–growth hormone remaining in the cells 
80 min after induction of secretion was deter-
mined using flow cytometry. As a positive control, 
the cells were transfected with STX5 (syntaxin5) 
siRNA, a known inhibitor of secretion (n = 3 in-
dependent experiments; ***, P < 0.001; multiple 
comparisons, one-way ANOVA, Dunnett’s multiple 
comparisons post hoc test). GH, growth hormone. 
(B) LC3-II levels were assessed by SDS-PAGE after 
knockdown of Sar1A and -B, Giantin, or VDP in 
HeLa cells. Actin levels demonstrate equal loading. 
(C) Bar graphs indicating the effect of knockdown, 
as in B, on httQ74 aggregation (**, P< 0.01; 
***, P < 0.001; odds ratio; n = 9). (D) Tomato-
p62 and DsRed were transfected into HeLa cells 
during the last 24 h of knockdown, as in B, and 
the effects were measured by SDS-PAGE. DsRed 
was used as a transfection control for tomato-
p62. Quantification of tomato-p62 levels relative 
to DsRed is shown in the bar graph (*, P < 0.05; 
**, P < 0.01; Dunnett’s multiple comparison post 
hoc test; n = 3). Values were normalized to control 
values for separate experiments. (E) LC3-II levels 
were assessed by SDS-PAGE after knockdown 
of Rab1b (bands shown are from the same gel, 
and unrelated lanes have been omitted) or Rab2. 
Actin and tubulin levels demonstrate equal loading. 
(F) Bar graphs indicating the effect of knockdown, 
as in E, on the percentage of httQ74 aggregation 
in transfected cells (***, P < 0.001; odds ratio; 
n = 9). (G) Tomato-p62 and DsRed were trans-
fected into HeLa cells during the last 24 h of knock-
down, as in E, and the effects were measured by 
SDS-PAGE. DsRed was used as a transfection con-
trol for tomato-p62. Quantification of tomato-p62 
levels relative to DsRed is shown in the bar graph 
(**, P < 0.01; Bonferroni’s multiple comparison 
post hoc test; n = 3). Values were normalized to 
control values for separate experiments. (A, C, D, 
F, and G) Error bars represent SEM.
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general secretion or whether autophagy does in fact depend 
on proper functioning of the secretory pathway, as implicated 
in early yeast studies (Ishihara et al., 2001; Hamasaki et al., 
2003; Reggiori et al., 2004). Understanding this difference may 
provide clues as to whether the autophagy defect caused by 
-synuclein is a generic consequence of the secretory defect or 
whether Rab1a inhibition of autophagy can be dissociated from 
a general secretory defect, suggesting a specific role for Rab1a 
in autophagy regulation. To begin to address this issue, we used 
RNAi to decrease protein levels of Rab1a effectors (Giantin 
and VDP [vesicle-docking protein 115]), early secretory pro-
teins critical for Rab1a secretion (Sar1A and -B), and Rab1b, an 
alternative isoform of Rab1, also involved in early secretion. After 
knockdown of these proteins, we analyzed the effects of their 
depletion on both secretion and autophagy to more closely look 
at the interplay of these two pathways. Knockdown of Rab1a, 
VDP, Giantin, and Sar1A and -B all partially inhibited consti-
tutive secretion (Fig. 4 A), as measured by the percentage of 
protein secreted 80 min after secretion induction. Rab1b (which 
appears to traffic different subsets of vesicles to Rab1a; Allan 
et al., 2000; Alvarez et al., 2003) inhibited secretion to a similar 
extent as Rab1a, Giantin, and VDP. Like Rab1a, knockdown 
of known Rab1a effectors Giantin and VDP and Sar1A and -B 
decreased LC3-II levels (Fig. 4 B), increased the percentage of 
cells with huntingtin aggregates (Fig. 4 C), and increased p62 
accumulation (Fig. 4 D). Unexpectedly, knockdown of Rab1b 
had the opposite effect on autophagy. Rab1b RNAi increased 
LC3-II (Fig. 4 E) levels, decreased the percentage of cells with 
huntingtin aggregates (Fig. 4 F), and decreased accumulation of 
p62 (Fig. 4 G).
Despite what little is known about differing functions of 
Rab1a and Rab1b, this clear divergence in their roles in the con-
text of autophagy was surprising. This led us to test another func-
tionally related Rab, Rab2. Rab2, even less characterized than 
Rab1b, has been shown to play a role in almost all aspects of 
ER–Golgi and intra-Golgi transport (Tisdale, 1999). Like Rab1b, 
knockdown of Rab2 increased steady-state LC3-II (Fig. 4, 
D and E) levels, decreased the proportion of cells with huntingtin 
aggregates (Fig. 4 F), and decreased p62 levels (Fig. 4 G). 
Although knockdown of Rab1b inhibited secretion, similar 
to Rab1a, it actually decreased aggregation of autophagy sub-
strates. Interestingly, the evidence supporting an independence of 
autophagy function from secretory function was further corrobo-
rated by chemical data showing that the well-known autophagy 
inducer, trehalose (Sarkar et al., 2007), caused a partial block 
in secretion (Fig. S2 C). Collectively, these data provide strong 
evidence for a specific Rab1a-related role in the regulation of 
autophagy, which is independent of any effects of general secretion 
on autophagy. These data suggest that certain secretory routes 
can be impaired without decreasing autophagosome synthesis, 
whereas pathways regulated specifically by Rab1a and its effec-
tors are critical for autophagy.
Rab1a is able to rescue the inhibitory 
effect of -synuclein on autophagy
To further confirm the hypothesis that -synuclein acts on autoph-
agy through Rab1a, we tested and confirmed that overexpression 
of Rab1a rescued the loss of autophagosomes caused by 
-synuclein overexpression. Overexpression of -synuclein sig-
nificantly reduced vesicle number when compared with control 
conditions. Coexpression of Rab1a-CFP rescued this decrease in 
vesicle count back to control levels (Fig. 5, A and B).
Figure 5. Rab1a can rescue the effect of -synuclein on macroautophagy. 
(A) The effect of cells expressing -synuclein–HA with empty CFP vec-
tor (control conditions) or Rab1a-CFP (rescue conditions) on tomato-LC3 
vesicles in SKNSH cells. HA-tagged wild-type (wt) huntingtin exon-1 frag-
ment with 23 polyglutamine repeats (httQ23) was used as a control for 
cells expressing -synuclein–HA in both control and rescue conditions. We 
have used a cut-off of 20 vesicles per cell in these experiments because 
the transient transfection of LC3 increases the baseline levels of vesicles 
(compared with endogenous LC3), and 20 vesicles is the mean observed 
under wild-type conditions in these cells. Bars, 20 µm. (B) Quantification of 
the effect of Rab1a-CFP on -synuclein–dependent reduction of LC3 levels 
(**, P < 0.01; two-tailed Student’s t test; n = 3). Error bars represent SEM.
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Figure 6. -Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells 
with -synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing -synuclein–GFP. Images shown 
are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with -synuclein overexpression or Rab1a knockdown. 
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-Synuclein and Rab1a affect the 
localization of the autophagy protein Atg9
We have shown that -synuclein causes secretory and Golgi de-
fects, consistent with Rab1a homeostasis disruption, -synuclein 
and Rab1a cause similar and specific defects in autophago-
some synthesis, and Rab1a can rescue the inhibitory effects of 
-synuclein on autophagy. This suggests that -synuclein in-
hibits autophagy via Rab1a. To identify a potential mechanism 
for the effects of -synuclein and Rab1a on autophagy, we ana-
lyzed steps critical to autophagosome synthesis. Neither Rab1a 
knockdown nor -synuclein overexpression affected key players 
in the autophagy signaling pathway such as mTOR (mammalian 
target of rapamycin) activity (Fig. S3 A).
We focused next on Atg9, as it is one of the only known 
transmembrane autophagy proteins (implicating the secretory 
pathway in its transport and glycosylation) and is required for 
autophagosome biogenesis. Atg9 localizes to the TGN and 
colocalizes with a portion of LC3-positive autophagosomes. 
Induction of autophagy with rapamycin or starvation causes 
Atg9 to move away from the TGN (Fig. S3 B) to autophago-
somes, causing a decrease in Atg9 colocalization with TGN 
markers and an increase in Atg9 colocalization with auto-
phagosomes (Fig. S3 C; Young et al., 2006). Rab1a knockdown 
and -synuclein overexpression did not overtly affect the gly-
cosylation of Atg9 (Fig. S4 A). However, both perturbations 
caused Atg9 to relocate from its normal perinuclear location, 
where it colocalizes with the TGN marker p230, to a diffuse 
distribution in cells (Fig. 6 A and Fig. S4 B). This mislocal-
ization, in cells overexpressing -synuclein or where Rab1a 
was knocked down, also manifested as a lower proportion of 
LC3 vesicles colocalizing with Atg9 and fewer Atg9 structures 
colocalizing with LC3 (after controlling for decreased LC3 vesicle 
number through the use of Mander’s coefficients; Fig. 6, C–E). 
This mislocalization is not a general characteristic of autoph-
agy inhibitors, as the normal perinuclear localization of 
Atg9 is unaltered in cells treated with LY290042 (a phos-
phatidylinositol 3-kinase inhibitor; Young et al., 2006), 
3-methyladenine, or bafilomycin A1, which are all unlike rapa-
mycin (shown as a positive control for Atg9 movement; Fig. S4 C). 
In addition, this characteristic alteration in Atg9 colocaliza-
tion is not seen after knockdown of Rab1b nor Rab2, both of 
which increased the colocalization of Atg9 and LC3 (Fig. S4, 
D and E) and decreased Atg9 colocalization with p230. This data 
are in agreement with our earlier findings (Fig. 4, E–G) show-
ing that Rab1b and Rab2 knockdown increases autophagy. 
Collectively, these data suggest that not only are the effects 
of Rab1a knockdown and -synuclein overexpression similar 
and relatively specific, but that the effect of Rab1a knockdown 
on autophagy is not simply caused by generic disturbances in 
constitutive secretion or Golgi structure, as indicated by the 
different effects of Rab1b and Rab2.
-Synuclein, Rab1a, and Atg9 affect 
omegasome formation via Atg9
Because very little is known about Atg9 regulation of autophago-
some synthesis, we looked more specifically at the effects of 
-synuclein and Rab1a on the formation of the omegasome. The 
omegasome is a newly characterized marker that is thought to be 
the precursor to the forming autophagosome. Cells expressing 
GFP-tagged double FYVE domain–containing protein (DFCP1) 
allow for the visualization of forming omegasomes. The double 
FYVE domain present on DFCP1 binds to phosphatidylinositol-
3-phosphate (PI(3)P) at the proposed site of formation of ER- 
associated nascent autophagosomes (Axe et al., 2008). PI(3)P 
plays a critical role in autophagy, and inhibition of PI(3)P synthe-
sis blocks autophagosome formation (Kihara et al., 2001; Suzuki 
et al., 2007). DFCP1-GFP–positive vesicles, called omegasomes, 
increase after treatment with known autophagy inducers and have 
been shown to colocalize with LC3 and Atg5. Thus, cells express-
ing GFP-labeled DFCP1 allow for the visualization of early 
events in autophagosome formation (Axe et al., 2008).
Knockdown of Rab1a and overexpression of -synuclein 
reduced omegasome vesicle count under basal conditions 
(Fig. 7, A–D). Overexpression of Rab1a was able to rescue the 
deficiency in omegasome formation caused by -synuclein 
overexpression and increase omegasome levels to nearly that 
of the control condition (Fig. 7, E and F). Interestingly, Rab1a 
overexpression can increase omegasome count above that of the 
normal basal condition but is unable to increase LC3 vesi-
cle formation above basel levels in -synuclein–expressing 
cells. The transition of the omegasome to a functional LC3-
positive autophagosome may be a potential rate-limiting step 
that cannot be overcome simply with an increase in omega-
some formation.
Because -synuclein and Rab1a appear to affect autoph-
agy through Atg9 mislocalization, we also tested the effects 
of Atg9 knockdown on omegasome formation to determine 
whether Atg9 acts upstream of omegasome formation. Like 
Rab1a knockdown and -synuclein overexpression, knock-
down of Atg9 decreased omegasome and autophagosome 
formation under basal conditions, indicating that Atg9 acts 
upstream of these processes (Fig. 7, A, B, and G). Thus, 
these data are compatible with a model whereby -synuclein 
impairs Rab1a activity, which, in turn, perturbs Atg9 func-
tion to reduce autophagosome formation at a very early point 
in biogenesis.
Golgi fragmentation can be seen in the p230 columns. -Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype 
which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocal-
ization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of 
endogenous Atg9 and LC3 in cells with -synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing 
-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes 
to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) 
(D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in 
E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or -synuclein overexpression (*, P < 0.05; 
**, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.
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Figure 7. -Synuclein, Rab1a, and Atg9 affect omegasome and autophagosome formation. (A) The effect of Rab1a and Atg9 knockdown on omegasome 
formation in DFCP1-GFP HEK293, human embryonic kidney cells. (B) Quantification of A (*, P < 0.05; one-way ANOVA, Dunnett’s multiple comparison 
post hoc test; n = 10). (C) The effect of -synuclein on omegasome formation in DFCP1-GFP HEK293 cells. httQ23-HA was used as a control for cells 
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Discussion
Our data show that overexpression of -synuclein impairs macro-
autophagy. This provides a mechanism whereby copy-number 
mutations of -synuclein contribute to PD. Because sporadic 
PD is also associated with -synuclein accumulation, our data 
may have much wider implications.
Our findings appear specific to wild-type -synuclein, as 
the PD-associated point mutants A53T and A30P had no effect 
on LC3-II levels (Fig. S1 A). This may be because either A53T 
and A30P have no effects or have different effects on autoph-
agy compared with the wild-type protein. Alternatively, these 
mutants do impair autophagy in a similar way to the wild-type 
protein, but their effects are masked by their known inhibition 
of CMA (Cuervo et al., 2004), which leads to a compensatory 
increase in autophagosome formation.
We have found that overexpression of wild-type -synuclein 
in vitro and in vivo inhibits autophagosome synthesis, as de-
termined by a range of different specific assays. These assays 
reveal a decrease in omegasome formation, a decrease in LC3-II 
lipidation, impaired LC3 vesicle formation, and accumulation 
of autophagy substrates (mutant huntingtin and p62). When 
viewed in the context of previous data showing that -synuclein 
affects Rab1a function (Cooper et al., 2006), we were interested 
in determining whether -synuclein acted via Rab1a on autoph-
agy. We found that knockdown of Rab1a mimicked the effects 
seen by -synuclein overexpression, by decreasing omegasome 
formation, decreasing LC3-II levels, and increasing autophagy 
substrates. Importantly, Rab1a expression was able to rescue 
the inhibitory effects of -synuclein on both omegasome and 
LC3 vesicle formation.
We believe that -synuclein and Rab1a exert their control 
on autophagy via a very early step in the initiation of autophago-
some synthesis, as Atg9 was found to be mislocalized with 
-synuclein overexpression and Rab1a knockdown. Atg9 knock-
down itself reduced both omegasome formation and LC3-II 
levels, indicating that Atg9 controls a step in autophagosome for-
mation upstream of omegasome formation.
These findings are important for understanding PD mo-
lecular pathogenesis and further understanding the regula-
tion of autophagy. Our data identify a new role for Rab1a in 
the regulation of autophagy. The effects we observe are not 
simply caused by a generic impairment of ER–Golgi trans-
port because other Rabs which mediate this step do not im-
pair autophagy when knocked down. Furthermore, the robust 
autophagy inducer trehalose (Sarkar et al., 2007) appears to 
decrease secretion (Fig. S2 C), suggesting that bulk secretion 
can be uncoupled from autophagy induction. Similarly, the 
absence of changes in Atg9 glycosylation with Rab1a knock-
down suggests that Atg9 transport, at least from the ER to the 
Golgi, is not overtly impaired. Our data are consistent with 
a model whereby other molecules trafficked via Rab1a (but 
not Rab2 or Rab1b) modulate Atg9 trafficking, which, in turn 
regulates omegasome formation.
Interestingly, in yeast, the Golgi-associated COG (con-
served oligomeric Golgi) complex is important for autophago-
some assembly and appears to also influence Atg9 trafficking 
(Yen et al., 2010). It will be informative to assess this process 
in mammalian cells and to also test whether specific perturba-
tion of later steps in the secretory pathway affects autophagy 
in mammalian cells. However, it is important to reiterate that 
our data suggest that certain secretory routes (e.g., Rab1b 
and Rab2) can be impaired without decreasing autophagosome 
synthesis, whereas pathways regulated specifically by Rab1a 
and its effectors are critical for autophagy. Thus, either Rab1a 
influences autophagy via a specific Rab1a-related secretory 
route or may be acting via a novel, secretory-independent func-
tion of Rab1a.
Although our data suggest that specific secretion-associated 
components regulate autophagy, recent publications have iden-
tified an interesting situation in which autophagy regulates a 
specialized form of secretion. The autophagosome participates 
in the secretion of acyl coenzyme A–binding protein (AcbA) 
in starvation conditions in various species of yeast by bypass-
ing the vacuole and fusing with the plasma membrane. This 
process involves the Golgi-associated proteins (GRASPs), 
autophagy proteins, plasma membrane SNARES, the endosomal 
compartments, and peroxisome activity (Duran et al., 2010; 
Manjithaya et al., 2010). These studies raise the possibility 
of a reciprocal interplay of the secretory pathway and the 
nonvacuole–lysosomal pathway. Although our findings involve the 
autophagosome–lysosome pathway and a secretory-independent 
function of Rab1a, it will be important to further elucidate the 
interaction of the secretory and autophagy pathways within 
mammalian cells and how a new Rab1a-specific regulation of 
autophagy fits into the intersection of these pathways.
The impairment of Rab1a function by overexpression of 
-synuclein will have cumulative effects on both the secretory 
pathway, as shown in Fig. 2 (A–C) and previously (Cooper et al., 
2006), and on autophagy. Although the effects we observe of 
-synuclein on secretion within mammalian cells are reproduc-
ible and consistent, these effects appear to be relatively minor 
compared with the effects we observe of -synuclein and Rab1a 
on autophagy. Cumulatively, these assays show a 30–50% de-
crease in autophagosome synthesis. Although this does not rep-
resent a complete block of autophagy (which would be lethal; 
Tsukamoto et al., 2008), a partial block of the magnitude we 
observed, or smaller, would be likely to manifest significant 
consequences over many decades in postmitotic neurons. It is 
of interest to note that reduction of -synuclein levels enhances 
expressing -synuclein–HA. (A and C) Arrows mark omegasomes. Images shown are single-plane images. (D) Quantification of C (*, P < 0.05; two-tailed 
Student’s t test; n = 10). (E) The effect of cells expressing -synuclein–HA with empty CFP vector (control conditions) or Rab1a-CFP (rescue conditions) on 
omegasome formation. HA-tagged wild-type huntingtin exon-1 fragment with 23 polyglutamine repeats (httQ23) was used as a control for cells expressing 
-synuclein–HA in both control and rescue conditions. Z-stack projections are shown. Arrows denote omegasomes. (F) Quantification of E (*, P < 0.05; 
two-tailed Student’s t test; n = 10). (B, D, and F) Error bars represent SEM. (G) Effect of Atg9 knockdown on LC3-II levels in SKNSH cell lysates. Actin was 
used to demonstrate equal loading. Bars: (A and C) 20 µm; (E) 10 µm.
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Importantly, our proposed mechanism for the inhibitory 
role of -synuclein on autophagy furthers our understanding of 
the disease (Fig. 8). Although the inhibition of early secretion 
by -synuclein may explain the dopaminergic defects seen in 
PD, it does not sufficiently explain the formation of inclusions 
and cell death characteristic of PD. In principle, multiplications 
of the -synuclein locus leading to increased protein levels of 
-synuclein will inhibit autophagy. The inhibition of autophagy 
increases accumulation of aggregate-prone proteins and sensi-
tizes the cell to proapoptotic assaults. Increased aggregation and 
apoptosis are characteristic of PD, and therefore, inhibition of 
autophagy by -synuclein overexpression may further explain 
the pathologies characteristic of PD. Collectively, the ability of 
-synuclein to inhibit both autophagy and secretion may act as 
a potent impetus for neurodegeneration.
Materials and methods
Cell culture
Human neuroblastoma cells (SKNSH), human cervical carcinoma cells 
(HeLa), and human embryonic kidney cells (HEK293) were maintained in 
DME supplemented with 10% fetal bovine serum, 100 U/ml penicillin/
streptomycin, and 2 mM l-glutamine (Sigma-Aldrich) at 37°C and 5% CO2. 
DFCP1-GFP–expressing cells lines were selected in 800 µg/ml and were a 
gift from N.T. Ktistakis (Babraham Institute, Cambridge, England, UK).
Constructs and siRNA were transfected in OptiMeM (Invitrogen) 
using Lipofectamine 2000 reagent (Invitrogen) according to the manufac-
turer’s instructions using 80 nM siRNA and were compared with control 
siRNA (nontargeting SMARTpool; Thermo Fisher Scientific). Wild-type 
-synuclein constructs were transfected at 1.5 µg per well, httQ74 con-
structs at 0.5 µg per well, LC3-tomato at 0.2 µg per well, Rab1a-CFP 
(previously characterized construct; Maier et al., 2009; gift from H. Sitte, 
Medical University Vienna, Vienna, Austria) at 1.5 µg per well, tomato-
p62 at 0.75 µg, and DsRed at 0.5 µg per well.
autophagy. Thus, it is likely that even small increases (or 
decreases) in the levels of this protein will modulate autoph-
agy. The cumulative effects of a partial inhibition of both 
the secretory pathway and autophagy may explain dopamine 
secretion defects and proteinaceous accumulation and cell 
death, respectively.
Overall, this situation appears to represent a specific ex-
ample of how the proteostasis of the whole cell can be disrupted 
by a specific aggregate-prone protein, a model which was pro-
posed by Gidalevitz et al. (2006) in another disease context. 
In this case, the culprit, -synuclein, impairs autophagy, a 
major route for the clearance of aggregate-prone intracytoplas-
mic proteins, and this in turn increases the concentration of such 
proteins and increases their probability of aggregation. How-
ever, the predicted outcome of reduced autophagic clearance 
will have pleiotropic effects. In addition to the accumulation 
of aggregate-prone proteins, the cells will not be as effective 
in clearing dysfunctional mitochondria (Twig et al., 2008) and 
will have increased susceptibility to certain apoptotic insults 
(Ravikumar et al., 2006); these are all processes that have been 
implicated in PD (Fig. 7 F; Cookson and van der Brug, 2008). 
Thus, autophagy inhibition caused by wild-type -synuclein 
may provide a unifying mechanism for many of the apparently 
disconnected cellular pathologies in PD. It is interesting to 
consider that there may be compensatory regulation of CMA 
and macroautophagy when one of these pathways is perturbed 
(Martinez-Vicente et al., 2008). However, if one considers that 
both macroautophagy and CMA are inhibited by wild-type 
-synuclein (Martinez-Vicente et al., 2008), this is likely to be 
particularly deleterious.
Figure 8. Cumulative molecular effects of 
-synuclein overexpression. Diagram illus-
trating the pleiotropic effects of increased 
intracellular levels of -synuclein on vital intra-
cellular pathways. The effects of -synuclein on 
macroautophagy would likely cause increased 
susceptibility to proapoptotic insults, mitochon-
drial dysfunction, and increased aggregation, 
which are all features of PD.
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For siRNA experiments, C1 cells were transfected with OnTargetPlus 
siRNA oligonucleotides (100 nM final concentration; Thermo Fisher Scien-
tific) using Oligofectamine (Invitrogen) as previously described (Motley et al., 
2003). For overexpression experiments, -synuclein–CFP or CFP was trans-
fected into C1 cells using HeLaMonster (Mirus) for 96 h and then assayed for 
secretion. Brefeldin A, a known inhibitor of secretion, was used at 2 µg/ml 
as a control for this assay.
To assess constitutive secretion, secretion of stably expressed GFP–
growth hormone was initiated by incubating C1 cells with 1 µM AP21998 
(ARIAD Pharmaceuticals) at 37°C in 5% CO2 for 80 min. Secretion was halted 
by placing cells on ice, and cells were detached from the dish by incubating 
them with trypsin-EDTA solution (PAA Laboratories) at 4°C for 2 h. The trypsin 
was quenched using DME supplemented with FCS, and the samples were then 
analyzed for EGFP fluorescence using a FACSCalibur flow cytometer (BD) 
at 0 and 80 min. Dead cells were excluded using 7-aminoactinomycin-D. 
For analysis of the -synuclein overexpression experiments, which required 
CFP and GFP fluorescence detection, samples were analysed on a Cyan ADP 
(Beckman Coulter).
To measure the amount of GFP secreted, each siRNA oligonucleotide 
or construct was transfected in duplicate. The first sample was used for the 
initial time point (0 min), and the second sample was used for the final time 
point (80 min). The mean fluorescence of each sample was measured, 
and the amount of GFP remaining in the cell was calculated using FlowJo 
software (Tree Star, Inc.).
Statistical significance analysis was performed using Excel soft-
ware for Student’s t test (overexpression experiments) and PRISM software 
(GraphPad Software, Inc.) for one-way analysis of variance (ANOVA; 
siRNA experiments). The percentage of secreted protein after 80 min was 
determined by dividing the GFP fluorescence at 80 min by the GFP fluor-
escence at 0 min. This ratio was normalized to empty vector (CFP) for 
-synuclein and brefeldin A.
Golgi fragmentation
Golgi were immunostained using anti-GM130 antibody in cells over-
expressing -synuclein–GFP or EGFP. Fragmented Golgi were recognized 
as dispersed, noncondensed GM130 staining, whereas nonfragmented 
Golgi were recognized as condensed, perinuclear, and ribbon-like GM130 
staining. The percentage of transfected cells with fragmented Golgi was 
counted in at least 200 cells of blinded experiments run in triplicate.
Drosophila strains
Pseudopupil assays were performed on progeny of the appropriate geno-
types, generated by crossing virgins of the genotype elav-GAL4C155; gmr-
Htt (exon1)Q1204.62 (Jackson et al., 1998) with flies expressing wild-type 
-synuclein (UAS--syn; Feany and Bender, 2000) and with flies express-
ing constitutively active Rab1 (y1 P{UASp-YFP.Rab1.Q70L}CG363812c w*; 
Zhang et al., 2007) or dominant-negative Rab1 (y1 w*; P{UAST-YFP.Rab1 
.S25N}mei-S33204; Zhang et al., 2007).
As a control for the derived fly lines, virgins of the isogenic w1118 
line (Ryder et al., 2004) or the pan-neural driver elav-GAL4C155 were 
crossed with males of each transgenic line to generate progeny to confirm 
that no insertions except gmr-Htt(exon1)Q120 resulted in neurodegenera-
tion. The same virgins were crossed with males y w; gmr-Htt(exon1)Q1204.62 
to assess the rate of neurodegeneration caused by mutant huntingtin.
Fly crosses and experiments were performed at 25°C. All crosses 
for individual experiments were performed at the same time and under 
the same conditions. Comparisons were performed using paired Student’s 
t tests using data from five to seven independent experiments, each based 
on 10 individuals of each genotype, in which 15 ommatidia each were 
scored. We thank M. Feany (Harvard Medical School, Boston, MA), 
G.R. Jackson (University of California, Los Angeles, School of Medicine, 
Los Angeles, CA), and the Bloomington Drosophila Stock Center for 
Drosophila stocks.
Mice
M7 -synuclein mice were a gift from V.M.-Y. Lee (University of Pennsylva-
nia, Philadelphia, PA). To generate the three possible mouse genotypes, M7 
homozygous were crossed to C57BL/6J, and the F1 was intercrossed to 
produce the three genotypes on the F2 (+/+, M7/+, and M7/M7). F2 mice 
were used in all experiments. All procedures were performed in accordance 
with the appropriate Home Office and Local Ethical Committee approval.
F2 mice were used in all experiments. F2 mice were genotyped by 
real-time PCR from ear-clip DNA. -Synuclein expression levels were veri-
fied by Western blotting. Half brains (22–23-wk-old males; n = 3 each) 
were homogenized in lysis buffer (0.5% Triton X-100 and 50 mM Tris HCl, 
Bafilomycin A1 was used at 400 nM for 4 h (Millipore). 3-methyladenine 
(Sigma-Aldrich) was used at 10 mM for 16 h. Rapamycin was used at 
0.5 µM for 4 h. Starvation experiments were conducted in HBSS for 4 h.
Aggregate quantification
EGFP-httQ74 aggregation was detected by direct immunofluorescence, 
whereas httQ74-HA aggregation was detected by immunostaining (primary 
HA antibody [1:500; Covance] and anti–mouse Alexa Fluor–conjugated 
secondary antibodies [1:1,000; Invitrogen]). The proportion of transfected 
cells with aggregates was scored (200 cells per coverslip). Experiments 
were performed blinded and in triplicate per three independent experiments. 
Statistics for aggregation assays were calculated as odds ratios (the ratio of 
aggregate-containing nuclei in each condition) with 95% confidence inter-
vals from the raw data. Odds ratios and p-values were determined by uncon-
ditional logistical regression analysis using the general log linear analysis in 
SPSS version 6.1 (SPSS Inc.).
Western blotting
Protein levels were assessed by standard SDS-PAGE techniques. Primary 
antibodies include anti-EGFP (Takara Bio Inc.), anti-HA (12CA5; Covance), 
anti-Rab1a, anti-Atg9 (both Abcam), antitubulin, and anti-LC3 (Novus Bio-
logicals). Quantification of protein levels by Western blotting was con-
ducted in ImageJ (National Institutes of Health) software for normal ECL 
development techniques and on the LI-COR Odyssey (BD).
Immunofluorescence and microscopy
Cells were grown on coverslips and fixed in 4% paraformaldehyde for 
10 min and then permeabilized with 20°C methanol for 4 min. For 
aggregation experiments using httQ74-HA, cells were permeabilized 
using 0.5% Triton X-100 in PBS. 4% goat serum (Sigma-Aldrich) in PBS 
was used for blocking and primary and secondary buffer. Coverslips 
were left in primary antibody overnight at 4°C. Secondary antibodies 
were conjugated Alexa Fluor antibodies (Invitrogen). All primary anti-
bodies used for Western blotting were used for immunostaining except 
anti-LC3 (Nanotools).
A confocal microscope (63× NA 1.4 Plan-Apochromat oil immer-
sion lens; LSM510 META; Carl Zeiss, Inc.) along with the LSM510 version 
3.2 software (Carl Zeiss, Inc.) was used for fluorescent, confocal micros-
copy involving immunofluorescent staining with Alexa Fluor–conjugated 
secondary antibodies or fluorescently tagged proteins. All confocal images 
were taken with a 63× oil immersion lens except for experiments involving 
the DFCP1-GFP HEK293 omegasome cell line, in which a 40× oil immer-
sion lens was used. Microscopy was performed on cells fixed on cover-
slips. Coverslips were mounted in Prolong Gold Antifade reagent (with 
DAPI; Invitrogen). ImageJ and Photoshop (Adobe) were used for further 
analysis and processing of confocal images (the specifics of software use 
for colocalization analysis and image processing are discussed in the next 
section). A microscope (Plan-Apochromat 60× NA 1.4 oil immersion lens; 
Eclipse E600; Nikon) was used for aggregate counting and Golgi frag-
mentation quantification.
Quantification of colocalization
Colocalization of Atg9 with Golgi (p230) and LC3 was imaged using 
an LSM510 META confocal microscope (63× NA 1.4 Plan-Apochromat 
oil immersion lens) along with the LSM510 version 3.2 software after 
immunostaining of endogenous proteins. 10 images of a mean of five 
cells per image were taken per condition per experiment. Each experi-
ment was run in at least two independent experiments. Exposure set-
tings were unchanged throughout acquisition. Cells were imaged in 
z stacks, and images were analyzed by the JaCoP plugin (Bolte and 
Cordelières, 2006) in the ImageJ software. Pearson’s and Mander’s 
(original, nonthreshold) coefficients were used for reporting colocaliza-
tion. Student’s t tests were performed in Excel (Microsoft) to determine 
statistical significance for colocalization coefficients. Images shown 
are z-stack projections or single planes of representative images using 
ImageJ and Photoshop software.
Secretion assay
The vector (pC4S1-FM4-FCS-hGH) encoding the pharmacologically regu-
lated reporter construct was obtained from ARIAD Pharmaceuticals (Rivera 
et al., 2000). The construct was modified so that EGFP was cloned in-frame 
between the signal sequence and the first FM4 aggregation domain. The 
reporter construct was then subcloned into the retroviral expression vector 
pQXCIP (Takara Bio Inc.). A stable cell line (referred to as C1) expressing 
the reporter construct was generated by virally transducing HeLa cells.
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